Circumventing autophagy inhibition

Area of Science:

• Oncology
• Cellular Biology
• Molecular Medicine

Background:

• Autophagy, a cellular recycling process, has a complex role in cancer, with preclinical studies suggesting a pro-tumorigenic function.
• Numerous clinical trials are investigating autophagy inhibition combined with standard therapies for various cancer types.
• Identifying cancer cell lines sensitive to autophagy gene loss is critical for therapeutic development.

Purpose of the Study:

• To review recent publications on autophagy's role in cancer.
• To explore mechanisms by which cancer cells circumvent autophagy inhibition.
• To understand resistance to autophagy inhibition for improved clinical strategies.

Main Methods:

• Utilized a novel, acute CRISPR/Cas9 assay to identify cancer cell lines sensitive to autophagy gene loss.
• Analyzed rare cell populations that circumvented autophagy inhibition after initial sensitivity.
• Investigated the role of NRF2 signaling in circumventing autophagy loss and maintaining protein homeostasis.

Main Results:

• Identified cancer cell lines acutely sensitive to autophagy gene loss within 7 days.
• Discovered rare clones that developed resistance to autophagy inhibition weeks later.
• Found that circumventing cells upregulated NRF2 signaling, increasing sensitivity to proteasome inhibition and NRF2 knockdown.

Conclusions:

• Cancer cells can develop resistance to autophagy inhibition through NRF2 pathway activation.
• Understanding resistance mechanisms is key to preventing tumor relapse.
• Preclinical studies can guide combination therapies to overcome autophagy inhibition resistance.